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We have read with great interest what written by Licker et al. with the title “Fluid therapy in thoracic surgery: «a zero-balance tar-get is always best!”.
Irrespective of the type of surgery, less fluid or too much fluid could be both 
harmful (1).
Why should we restrict fluids in thoracic surgery?
An association has been found between the incidence of acute lung injury 
(ALI) and/or adult respiratory distress syndrome (ARDS) and the volume of 
fluid infused in the intraoperative and postoperative periods (2, 3).
On this basis, a conservative strategy about “fluid maintenance” and “fluids 
challenge” seem to be a rational approach. In this way we totally agree with 
Licker et al. that 1-3, as we stated, or 3-4 mL/kg/h, as they stated, of intraop-
erative fluids maintenance is a reasonable choice.
But apart from intraoperative bleeding condition, each time a fluids chal-
lenge (FC) should be administered the clinician should understand whether 
the patient has a preload reserve that can be used to “restore tissue perfusion”, 
with particular attention “when the patient needs it!”
Why we have to measure cardiac output (CO), in selected high risk 
surgical patients? 
Because fluid test can be negative and further FC has to be avoided. This is 
mandatory and in thoracic anesthesia with the thorax open, the anesthetist 
cannot use hemodynamic dynamic indices (4, 5). Only a CO (or simply the 
stroke volume) measurement can help you to understand if the patient is a 
fluid responder or not (6).
Goal directed therapy (GDT) is intrinsically linked to the concept of restrict-
ed fluid regime, but not all patients can restore tissue perfusion with a FC 
(i.e. limited cardiac reserve), and an inotrope may be used, or on the other 
hands some patients could not tolerate fluids (i.e. advance diastolic dysfunc-
tion grade III or IV). This approach can be see as a “tailored hemodynamic 
optimization” instead of following normal hemodynamic values (7, 8).
The evidence in literature so far in very limited and sometimes with conflict-
ing results (9, 10) Hemodynamic functional dynamic indices, pulse pressure 
variation (PPV) and SVV, are the only reliable predictors of fluid respon-
siveness under strict conditions, while in routinely clinical practice factors 
including low tidal volume, cardiac arrhythmias, and the calculation method 
(the software) can substantially reduce their predictive value (4).
In thoracic surgery, the “open chest” preclude its use (5). We disagree with Lick-
er et al. also because “volume responsiveness” is not equal to volume deficiency. 
To cite a recent editorial by Takala, (11) “giving volume to fluid responders as long 
as they respond should not become the iatrogenic syndrome of the decade”.
However, it is also true that trans-esophageal echocardiography (TEE) in the 
last decade has became increasingly used to identify an unexpected situation in 
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case of low-risk patient undergoing low-intermediate risk surgery as 
“reactive” hemodynamic approach (12).
Hemodynamic monitoring for which patients?
We think that the benefits of GDT are greater in patients who are 
at higher risk of complication, more than mortality (ASA 3, 4). 
In these patients, postoperative recovery in the intensive care unit 
(ICU) should be planned before surgery for all patients requiring 
postoperative organ support (i.e. cardiac, respiratory, renal support) 
in fact the goals of GDT should be maintained for up to 6-8 post-
operative hours (13).
Should we give fluids to correct oliguria?
Today everybody agree that initial intraoperative oliguria (<0.5 
mL/kg/h for 3-4 hours) should not be used as the sole trigger for 
fluid administration, including high risk surgical patients!
This must be taken into our mind to improve the quality of anes-
thesia management we suppose to know very well.
Anyway, postoperative AKI has to be prevented since the immedi-
ate postoperative period, and not only in thoracic surgery! “Fluid 
therapy” could be minimized if any patient would be free to drink 
clear fluid (first of all they have to drink water) since the first post-
operative hours… and not the day after the surgery. This is the best 
way to balance the appropriate fluid need in the human body… if 
the patient drinks! We should apply the bundles we considered ap-
propriate including the Enhanced Recovery After Surgery (ERAS) 
program (14), Fastrack or the most recent Perioperative Surgical 
Home (PSH) pathway (15).
Brandstrup demonstrated that in colo-rectal surgery a restricted 
approach reduced post- operative complications and death (16). 
Some studies in vascular patients undergoing major abdominal 
aortic surgery failed to identify specific superior of this fluid regi-
mens (17) and the available result obtained with the “zero-balance” 
approach mainly in colon-rectal surgery should not be translated 
“tout court” in thoracic surgery.
Finally, several studies seem to suggest that in low-risk patients un-
dergoing minor to intermediate risk surgery - video assisted thorac-
ic surgery (VATS) -, liberal strategy (non restrictive) may be prefer-
able because it reduces nausea, vomiting, drowsiness, dizziness and 
length of stay (18, 19).
What type of fluid should be given?
Normal saline solution has been used for over 50 years as an intra-
operative, resuscitation and maintenance fluid; however its exces-
sive use can lead to hyperchloremic acidosis (20). There is currently 
a debate regarding the morbidity associated with this condition, 
although its incidence is considered to be very low. The British 
Consensus Guidelines on Intravenous Fluid Therapy for Adult 
Surgical Patients recommend the use of balanced crystalloids rather 
then just saline solution to avoid hypercloremic acidosis (21). So 
we agree with Licker et al. about normal saline but disagree about 
colloid. The use of colloids in place of crystalloids, is disputed given 
the uncertainty regarding their safety and is outside the scope of 
this debate. Briefly, the European Medical Agency – EMA - after 
suspending hydroxyethyl starch (HES) use in June 2013 revised 
its decision in October announcing that the HES may continue to 
be used in certain conditions i.e. patients with acute hypovolemia 
secondary to blood losses in the operating room and without renal 
insufficiency. EMA a part, starches, on their side, seem to have a 
physiological rationale very interesting for their use in patients with 
an intact capillary (22).
How can we conclude?
The gray zone from a point of view of the statistical results in stud-
ies, close to this specific field, suggests us to give intraoperative IV 
fluids only tailoring the approach on the single patient (23).
Usually patients scheduled for elective surgery (including thoracic 
surgery) are not hypovolemic. In the intraoperative period if the 
patient is hypovolemic, it is rarely (bleeding) and needs fluids, we 
have to give fluids only if the patient is a fluid responder. This is 
mandatory in case of high-risk surgical patients. With the chest 
open, only a CO monitoring, according to the SV improvement, 
leads the anesthetist to the right way to give fluids or not, to reach 
the right hemodynamic target.
The last but not the least, if the patients drinks water until 2 
hours before the surgery and as soon as possible after the surgery 
(ERAS, PSH program etc…), we do not need to give so many 
fluids!
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